(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million, granting the pharma giant ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

The alliance extends a deal streak in genetic medicine for Lilly and hands the company rights to an experimental treatment ...

MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

A groundbreaking new procedure has restored the vision of 14 people with blinding cornea injuries in one eye. To treat this, the researchers and surgeons transplanted corneal cells from the healthy ...

Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...

The Duke Reading Center, which specializes in the analysis of retinal images, collaborated with Sina Farsiu, professor in the ...

This ocular condition happens as the result of a slight eye misalignment, which can cause symptoms such as dizziness and blurry vision. Treatment includes specialty lenses and vision therapy. Share on ...

FARGO - When Bergen Lindahl was about 3 years old, she couldn't sit still when her mother read to her. "She was never curious about the words. She was only curious about the pictures," mom Beth says.

For more information about MBKU, visit https://ketchum.edu/.

Which eye problems should parents watch for in children and teenagers? Learn about the five most common conditions and when to act.